Provost, OSU Center for Health Sciences
Dean, College of Osteopathic Medicine
Chair and Professor of Pediatrics
Education | Professional Experience | Fundraising and Development | Service | Program, Curriculum, Research Development | Publications, Presentations and Research | Professional Development Activities | Honors & Awards
Pediatric Residency Program, Tulsa Regional Medical Center, Tulsa, Oklahoma (1998-2001).
Doctor of Osteopathic Medicine, Oklahoma State University, College of Osteopathic Medicine (1998).
Associate of Science, Connors State College, Warner, Oklahoma (1992).
2011 to Present
Provost, Oklahoma State University Center for Health Sciences; Dean, Oklahoma State University College of Osteopathic Medicine; George Kaiser Family Foundation Chair in Medical Excellence and Service; Saint Francis Health Systems Endowed and Professor of Pediatrics, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma.
Responsibilities of this position include: chief academic officer of the Center for Health Sciences (CHS) and College of Osteopathic Medicine (COM) responsible for the academic operation of the CHS and the COM; development of relationships to further the interests of academic, medical research, and service programs associated with the CHS and the COM; development and implementation of current and innovative medical school curriculum; responsible for personnel actions of faculty, and budgetary control of the COM; and development and implementation of quality osteopathic medical education, biomedical graduate education, research, and service learning programs throughout the CHS. Provide promotion and tenure recommendations to the Provost and Senior Vice President, OSU and the President, OSU-CHS; support the education, research, and service missions of OSU-CHS, and the “One University-Multiple Campuses” philosophy; provide leadership in the acquisition of state, federal, and private funds; and maintain positive and productive relationships with various constituencies, and state and local government as directed by the President, OSU-CHS. Admit new students, confer degrees and certificates, and as appropriate provide authorization for suspension, dismissal and leave of absence of students; ensure the COM is in compliance with pertinent policies, procedures, and regulatory and statutory standards; and ensure development and implementation of strategic planning and operational plans associated with all administrative and financial functions under the purview of this position. Inform the President, OSU-CHS, and as directed by the President, OSU-CHS, inform the OSU A&M Board of Regents and the Oklahoma State Regents for Higher Education concerning the status, needs, and accomplishments of the COM and the CHS, and engaged in other activities as assigned by the President, OSU-CHS as needed. Lead the development of a “medical home” model for health care for the entire OSU system; provide “medical home” model expertise and support to the other institutions under the OSU A&M Board of Regents and provide leadership in creating a diverse workforce in all areas of the university, especially the administrative and healthcare areas.
2009 to 2011
Interim Vice President of Academic Affairs; Saint Francis Health Systems Endowed Chair of Pediatrics; Chairman, Department of Pediatrics; and Professor of Pediatrics, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma.
Responsibilities of this position include: Serving on the President’s and Dean’s Management Team, and as chief academic officer for the institution providing direct oversight of all Associate Deans and Academic Programs to include Rural Health, Clinic Operations, Biomedical Sciences, Clinical Education, Graduate Medical Education, Graduate Studies, Enrollment Management, and Clinical Research; provide direct supervision of the Office of Education & Development, Office of Academic Affairs and Office of Medical Informatics; coordination of faculty and academic needs with fiscal affairs and human resources; oversight of Promotion & Tenure process; approval of all faculty appointments and promotions; approval of all adjunct faculty appointments; approval of faculty development programs and Faculty Senate Committee appointments; evaluate and allocate faculty resources; oversight of curriculum and curriculum evaluation, providing leadership and direction in curriculum revision, leadership for student recruitment strategies and admissions program development; final approval of medical student admissions and leave requests, handle all legal matters related to student dismissals and student grievance process; work collaboratively with Chief Financial Officer and Director of Human Resources for purposes of recruitment and promotion; provide leadership and final decision on selection of electronic medical record system for the OSU-CHS Clinic system; serve as a liaison to the President’s Office for conflict management and resolution pertaining to faculty, graduate medical education, and students; build and maintain relationships integral to the continued success of the Center for Health Sciences to include academic partners, community partners, potential donors, and legislators; generate private funds for the support of academic and clinical programs.
Chairman, Department of Pediatrics and Saint Francis Health Systems Endowed Chair of Pediatrics, Oklahoma State University Center for Health Sciences– Tulsa
Responsibilities of this position include: providing leadership and vision in matters related to the educational, research, and service mission of the Department of Pediatrics; serving as a liaison between the Department of Pediatrics and other College units and Colleges within the University; supervising the planning, delivery, and evaluation of the teaching programs of the Department of Pediatrics in the outpatient clinic, OSU Medical Center, and Saint Francis Children’s Hospital; approve appointments of adjunct faculty and hiring of full and part time faculty within the department; assign personnel to instructional and related activities as requested by the Senior Associate Dean; prepare and maintain departmental policies related to Promotion, Tenure, and Post Tenure Review; recommend personnel actions pertaining to acquisition, promotion and/or tenure, retention, and dismissal; conduct regularly scheduled meetings with the members of the Department of Pediatrics; serve as the final arbitrator in the event of a grievance regarding departmental matters; recommend programs for development and enrichment of the department and department personnel; prepare requests for services, space, and equipment required to reasonably carry out the functions of the department; serve on various college committees as requested; develop and encourage clinical research within the department; evaluate and establish instructional goals; represent the department on the Council of Chairs; provide oversight in the management of departmental practice plan including the distribution of earnings to physicians; development and oversight of departmental budgets; responsible for building and maintaining external relationships key to carrying out the mission and vision of the Department of Pediatrics to include academic partners, community partners, and potential donors.
During the time I’ve served in this capacity I developed the premier hospitalist program at Saint Francis Children’s hospital, implemented the Medical Home Model & standardized patient encounters, recruited a full pediatric subspecialty adjunct faculty, implemented the CLIPP program online curriculum and online testing, developed and implemented the pediatric simulation lab, reorganized the pediatric clinic to improve patient satisfaction by enhancing continuity of care and facilitating better physician/ patient relationships, doubled the revenue of the pediatric practice from 2004, and personally maintained a full scope of clinical practice, including, hospital, clinic, and call.
Full Time Faculty– Assistant Professor, Associate Professor, Acting Chair, Oklahoma State University Center for Health Sciences- Tulsa, Oklahoma.
As a fulltime faculty member in the department of pediatrics I was involved in patient care while teaching medical students and residents at college ambulatory clinics, as well as the hospital inpatient service. I presented two lectures on web based video curriculum; developed a pediatric case for Clinical Problem Solving Course; provided lectures to pediatric residents, interns, and students on pediatric service; participated in original research and numerous clinical research trials. I served as Acting Chair of the Department of Pediatrics in 2003 while the Department Chair was on medical leave.
I was promoted to Associate Professor with tenure in 2007 and to Full Professor in 2009. Promotion with tenure to Associate Professor is granted by the institution after consistent performance in research, education, and service. Tenure is a life-long commitment to the faculty member and is evidence that the faculty member’s contribution is a wise investment to the University and academic unit. Departmental Guidelines for Promotion & Tenure are based on research and innovation, education, and service.
Assistant Residency Program Director, Oklahoma State Center for Health Sciences, Tulsa, Oklahoma
As Assistant Residency Program director I attended Post Graduate education meetings at Tulsa Regional Medical Center; participated in resident annual reviews; monitored the program for integration of osteopathic principles and practices; integrated core competencies for residents and interns; evaluated residents at least annually on their proficiency in the utilization of osteopathic principles and techniques through observed clinical encounters and chart review; integrated board review activities into the residency program; advised residents on rotation selection and compliance for graduation; monitored resident logs for sufficient procedure volume and proficiency; and worked with the Office of Graduate Medical Education to ensure compliance with the American Osteopathic Association.
Co-Course Coordinator, Health Promotion & Disease Prevention, Oklahoma State Center for Health Sciences
Responsibilities include: annual review and revision of curriculum ; auditing all lecturers; scheduling guest lecturers; working with lecturers on lecture content; proctoring mid-term and final exams; providing 2 hours of lecture and test questions.
Muskogee Children’s Clinic, Private Practice Muskogee, Oklahoma
I maintained a full scope of pediatric practice to include newborn and pediatric patients and direct patient care in the outpatient clinic and hospital. I attended high risk deliveries and was responded for pediatric emergencies and codes in the ER. In addition, I was responsible for supervision of office staff and billing and collections, adjunct clinical faculty, and served as a preceptor for OSU College of Osteopathic Medicine.
Institutional Review Board-member 2002-2003
Interdisciplinary Research Group - member
Acting Chairman of the Department of Pediatrics August 2003
Faculty Affairs Committee 2003-2006
Faculty Affairs Committee – Chairman 2004-2006
Academic Standards Committee-member 2004-2006
Participated in the revision of the Academic Standards Handbook
Strategic Planning Council – Co Chairman 2003-2004
Interim Pediatric Department Chairman June 2004
Co Course Coordinator Health Promotion Disease Prevention
Vice Chairman Department of Pediatrics, OSU Medical Center 2005-2009
Search Committee for Associate Dean of Clinical Education- member
Search Committee for Director of Office of Education and Development- member
Search Committee for Emergency Medicine Faculty- member
Prospective Student Interviewer 2005-2008
Selection Committee-Regents Outstanding Research Award- member
Council of Chairs- June 2005
Sub-committee on Indirect Medical Education Distribution Planning- member
OSU Physicians Practice Plan Board- member 2005
OSU Medical Center Board- member 2006-2008
Sub-committee on OSU Medical Center Physician Recruitment- Chair
Sub-committee on Clinical Track Faculty Promotion Guidelines
Interim Vice President of Academic Affairs 7/09 - 1/11
Saint Francis Children’s Hospital Graduate Medical Education Committee
Saint Francis Children’s Hospital Search Committee for Pediatric Neurologist
Saint Francis Children’s Hospital Search Committee for Pediatric Intensivist
Saint Francis Children’s Hospital Search Committee for Pediatric Nephrologist
Saint Francis Children’s Hospital Search Committee for Pediatric Cardiovascular Surgeon
National Board of Osteopathic Medical Examiners:
Part II Item Writer 2001-2007
Part III Item Writer
COMLEX Physical Exam Standard Setting Committee- 2009
American Osteopathic Board of Pediatrics Trustee 2007- present
Job Task Analysis Expert Panel- member
Item Reviewer 2007- present
Continuous Osteopathic Certification-Growth & Development Expert Panel-member
American Osteopathic Association:
Competency Based learning Conference 2002
House of Delegates-Summer 2000 Chicago Illinois
House Of Delegates 2009 Chicago Illinois
Oklahoma Osteopathic Association Trustee 2008-present
Legislative Committee 2002-2003
Post Graduate Education Committee 2003-2005
Oklahoma State Genetics Board-member 2002- present
OOA Board of Trustees- Member-2008-present
Bureau on Membership- member
House of Delegates 2009- Alternate
Physician Grievance Committee-member 2009-2010
Bureau of Member Services- Chair
Tulsa Coalition for Children’s Health Board- member 2004- present
Saint Francis Children’s Hospital Medical Executive Committee- member 2006- present
OSU Medical Center Board of Trustees- 2006-2008
Ronald McDonald House Charities Board of Directors- 2006-2009
Oklahoma Medical Reserve Corps. 2005- present
Realignment of research reporting structure to Chief Academic Officer
Developing strategic plan and initiatives to reallocate faculty resources, increase translational research, and expand graduate programs
Leading development of an innovative experiential based curriculum which includes early clinical experience and team based teaching from biomedical, behavioral, and clinical faculty
Instituted early clinical experience and reflection in Health Promotion Diseases Prevention Course
Developed Partners in Professionalism to be introduced to 1st year students in collaboration with Clinical Education and the Examiners Board
Initiated the development of Service Based Learning on the OSU-CHS Campus
Developed Rural Health Primary Care Early Admissions Program with OSU College of Agriculture and Natural Resources and OSU Tulsa
Developed a strategic admission plan to increase our applicant pool and increase the number of physicians practicing in rural Oklahoma
Implemented the COMLEX shelf exams on all required rotations to track student preparation for licensure board exams and evaluate the quality of the clerkship sites in preparing the students for Part 2 Boards
Reinstituted Career Development Program and created an Academic Skills Counselor
Leading the implementation of a new software program that will give OSU-CHS the capability to track students’ grades, competencies, and build individual student portfolios
Created the Executive Committee on Educational Policy, Curriculum, and Oversight to foster communication and cooperation across academic units to improve educational policy, curriculum and student oversight
Created the Executive Committee on Educational Enhancement to foster communication and cooperation to cultivate the learning environment to build a community of shared resources and opportunities that enhance educational endeavors across the OSU-CHS system
Instituted online didactic programs in all core rotations to provide an equal didactic experience to all students on their clerkship regardless of site, and to ensure adequate preparation for Part 2 Boards
Pediatric Sinusitis: The Importance of Diagnosis and Treatment. Journal of the American Osteopathic Association-May 2001 Supplemental
OSU Vanguard Journal Highlighted and sited in article as Chair of Pediatrics-Clinical Research
Common Pediatric Illnesses and What You Can Do At Home From the Perspective of “Dr. Mom” March 2004, Mom’s In Motion, Saint John’s Medical Center
Pediatric Development Birth to Age Two, Oklahoma State University-College of Osteopathic Medicine, September 2002
Neonatal Sepsis, Oklahoma State University –College of Osteopathic Medicine, Video Lecture Series-2002-Present
Fluids and Electrolytes, Oklahoma State University-College of Osteopathic Medicine, Video Lecture Series 2002-present
Common After Hours Calls, Oklahoma State College of Osteopathic Medicine, Academic Afternoon- 2006
Summertime Safety, Tulsa Public Schools Education Television Station-Channel 20, Spring 2005
Pool Safety, Summer 2001, Fox 23 News
Protein C&S Deficiency-Case Report, Poster Presentation- ACOP Convention Fall 2004
Transition Clinic Model For Special Needs Adolescent & Children
AAP/ACOP Spring Convention-2007
Assisted Deliveries As A Risk for Otitis Media in the First Two Years of Life, Oklahoma State University-Center for Health Sciences, Poster Presentation-Research Day, February 2006
Prebiotics in Infant Formula, Abbott Nutrition Speaker Bureau
Prebiotics & Probiotics In Infant Health & Nutrition, OSU-COM Primary Care Update, 2008
Tulsa World. COM Interviews, Interviewed regarding various pediatric illnesses and safety issues, 2002-present
HPV Vaccine & Vaccine Safety, OOA Annual Convention, 2009
Pediatric Respiratory Emergencies, OOA Summer Seminar, 2010
How Your Learning Style Affects Your Teaching Style-ACOP, San Francisco Clinical Study: ViroPharma Protocol 637-302, Sub Investigator, An Observational Study to Characterize the Disease Course and Outcome of Respiratory Syncytial Virus Nov. 2000-2001
Clinical Study: ViroPharma Protocol 637-303, Sub Investigator, An Observational Study to Characterize the Disease Course and Outcome of Respiratory Syncytial Virus (RSV) in High-Risk Infants and Young Children, Nov. 2000-2001
Clinical Study: Merck Research Laboratories Protocol 006-00, Sub Investigator, Rotavirus Safety and Efficacy Study, April 2002-present
Clinical Study: Merck Research Laboratories Protocol 010-00, Sub-Investigator, A Comparison of the Safety, Tolerability, and Immunogenicity of MMR II Manufactured from the 2003 Measles Stock Seeds with Recombinant Human Albumin (rHA) Versus Currently Licensed M-M-R II Manufactured from the 1967 Measles Stock Seeds With Human Serum Albumin (HAS) in Healthy Children 12 to 18 months of Age.
The Safety Check Study, American Academy of Pediatrics and Wake Forest University School of Medicine, Co-Investigator
Preliminary Investigation of the Nutrition Education Component of a Proposed Multidisciplinary Wellness Program for Overweight Adolescents In a Medically Underserved Population, Sub Investigator- Pending IRB Approval
Clinical Study: Sanofi-Pasteur Study GRC28, Subinvestigator, Efficacy of Fluzone 2 to 6 Months of Age, October 2005-February 2006
Clinical Study: GSK, subinvestigator, Efficacy of Combination Hib-MenCY-TT009/010,2006
Clinical Study: Merck Pharmaceuticals, Human Pappillomavirus Vaccine Study(HPV)-Phase III for Gardisil, 2006
Clinical Study: APPLES: A Prospective Pediatric Longitudinal Evaluation To Assess The Long-Term Safety Of Tacrolimus Ointment For The Treatment of Atopic Dermatitis
Clinical Study: An Open, Randomized, Multi-Center Study of the Safety, Tolerability, and Immunogenicity of VAQTA Given Concomittantly with ProQuad and Prevnar in Healthy Children 12 Months of Age
Assisted Deliveries as a Risk Factor for Acute Otitis Media in the First Year of Life, Primary Investigator-in preparation for submission to IRB
Clinical Study-Subinvestigator: An Expanded Phase 1/2a Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Immunogenicity, and Viral Shedding of MEDI-560, A Live Attenuated Recombinant Parainfluenza Virus Type 3 (PIV3) Vaccine, Administered Intranasally to Healthy Infants 1to <12 months of Age
Clinical Study-Subinvestigator: Open-label, Randomized, Multi-Center Study to Evaluate the Safety, Tolerability and Immunogenicity of VAQTA Given Concommitantly With PedvaxHIB and Infanrix in Healthy Children Aged 15 Months of Age
Clinical Study- Subinvestigator: A Phase 3 Open-Label, Randomized, Multi-Center Study to Evaluate the Safety and Immunogenocity of ProQuad Vaccine When Administered Concommitantly with Novartis Meningococcal ACWY Conjugate Vaccine to Healthy Toddlers
Clinical Study-Subinvestigator: A Phase 3, Open-Label Trial Evaluating the Safety, Tolerability, and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine in Healthy Children Aged 15 Months to 17 Years in the United States
Clinical Study-Subinvestigator: A Randomized, Single-Blind, Placebo-Controlled, Phase 2 Trial of the Safety, Immunogenicity, and Tolerability of Meningiococcal Serogroup B (MnB) rLP2086 Vaccine at Doses of 60 micrograms, and 200 micrograms in Healthy Adolescents Aged 11 to 18 Years
Clinical Study-Subinvestigator: A Phase 3b, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine when Administered with Routine Infant Vaccinations to Healthy Infants
Clinical Study-Subinvestigators: A Phase II, Randomized, Observer-Blind Controlled Multicenter Study to Assess Immunogenocity and Antibody Persistence Following Vaccination with GSK’s Candidate Combined Measles, Mumps, Rubella Vaccine (MMR) Versus MMR II According to a One-Dose Schedule, Both Administered Subcutaneously at 12-15 Months of Age, Concomitantly with Hepatitis A Vaccine (HAV), Varicella Vaccine (VV), and Pneumococcal Conjugate Vaccine (PVC) but at Separate Sites
Clinical Study-Subinvestigator: A Phase 3, Randomized, Active-Controlled, Double-Blind Trial Evaluating the Safety, Tolerability, and Immunogenicity of 3 Lots of 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants with Routine Pediatric Vaccinations in the United States
Clinical Study-Subinvestigator MedImmune Protocol MI-CP147: A Phase 1/2a, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Immunogenicity, and Viral Shedding of MEDI-559, a Live Attenuated Intanasal Syncytial Virus in Healthy 1 to <12 Month Old Children
Clinical Study-Sub Investigator MediImmune Protocol MI-MA213: The REPORT Study: An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Weeks Gestational Age)-Outcomes and Risk Tracking Study
Clinical Study Subinvestigator GSK Protocol HIB-097 (112957): Partially double blind study to evaluate consistency and immunogenicity of 3 lots of GSK Biologicals Hib vaccine 208108 versus ActHIB and Penatacel at 2,4,6,and 15-18 months of age in healthy infants
Clinical Study Sub Investigator GSK Protocol TOC110978: A Randomized, Double-Blind, Double Dummy, Comparative, Multicenter Study to Assess the Safety and Efficacy of Topical Retapamulin Ointment, 1% versus Oral Linezolid in the Treatment of Secondarily-Infected Traumatic Lesions and Impetigo Due to Methacillin- Resistant Staphylococcus aureus
Clinical Study-Subinvestigator GSK Protocol MMRV-054 PRI: A Phase 2, Randomized, Observer Blind, Multicenter Study of GlaxoSmith Kline Biological’s Combined Measles-Mumps-Rubella-Varicella (MMRV) versus ProQuad, According to a One Dose Schedule, Both Administered Subcutaneously at 12-14 Months of Age, Concommitantly with Hepatitis A Vaccine (HAV) and Pneumococcal Conjugate Vaccine(PVC) but at Separate Sites
Sarah Jane Pediatric Brain Injury-Regional Lead Center- PI selected for $3 million dollar grant
Pfizer Investigator Initiated-Co Primary Investigator Protocol: Analysis of Resource Utilization in High Risk Pediatric Patients in Methicillin-Resistent Staphylococcus aureus at the Children’s Hospital of St. Francis in Tulsa, Oklahoma- funded by Pfizer
The Impact of Linezolid versus Vancomycin on Resource Utilization among Pediatric Hospital Acquired Pneumonia Patients with Resistant Gram Positive Bacteria. Jaime G. Deville M.D., Jeffery J. Bergman D.O., Ozlem Equils M.D., Verna L. Welch Ph.D., Kayse Shrum D.O., Mark Bounthavong, Stanley Grogg D.O., American Thoracic Society International Conference. New Orleans, LA. May, 2010 Poster Presentation.
Methicillin Resistant Staphylococcus aureus (MRSA) Infections in Complex Pediatric Patients. Jeffery J. Bergman D.O., Kayse Shrum D.O., Verna Welch Ph.D., Natalie Dick D.O., Nicole Willis D.O., Stanley Grogg D.O., Oklahoma State Univerisity College of Health Sciences Research Symposium. Tulsa, OK. February 2010 Oral Presentation.
The Clinical Characteristics of Methicillin Resistant Staphylococcus Aureus (MRSA) Infections in Complcated Pediatric Patients. Jeffery J. Bergman D.O., Kayse Shrum D.O., Verna Welch Ph.D., Natalie Dick D.O., Nicole Willis D.O., Stanley Grogg D.O., American Academy of Pediatrics Annual Meeting, San Francisco, CA. October 2010.
Differences Among High-Risk (HR) and Non-High-Risk (NHR) Pediatric Patients with Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus (MRSA). Laura A. Puzniak Ph.D., M.P.H., Jeffery J. Bergman D.O., Verna L. Welch Ph.D., Charles Thompson M.D., Kayse Shrum D.O., Stanley Grogg D.O., Infectious Diseases Society of America, Vancouver, Canada. Abstract submitted and approved for meeting October 2010.
Skin and Skin Structure Infections (SSSI) Caused by Methicillian Resistant Staphylococcus aureus (MRSA) Among High-Risk (HR) and Non-High-Risk (NHR) Pediatric Patients. Laura A. Puzniak Ph.D., M.P.H., Jeffery J. Bergman D.O., Verna L. Welch Ph.D., Charles Thompson M.D., Kayse Shrum D.O., Stanley Grogg D.O., Infectious Diseases Society of America, Vancouver, Canada. Abstract submitted and approved for meeting October 2010.
Resource Utilization in Pediatric Patients Treated with Linezolid or Vancomycin for Hospital Acquired Pneumonia Caused by Resistant Gram Positive Bacteria. Jaime G. Deville M.D., Jeffery J. Bergman D.O., Ozlem Equils M.D., Verna L. Welch Ph.D., Kayse Shrum D.O., Mark Bounthavong, Stanley Grogg D.O., 48th Annual Meeting Infectious Disease Society of America, Vancouver, British Columbia, Canada, Poster Presentation October 2010
Resource Utilization Among Pediatric Patients Treated with Linezolid or Vancomycin for Hospital-Acquired Pneumonia Caused by Resistant Gram-Positive Bacteria. Jaime G. Deville M.D., Jeffery J. Bergman D.O., Ozlem Equils M.D., Verna L. Welch Ph.D., Kayse Shrum D.O., Mark Bounthavong, Stanley Grogg D.O., manuscript accepted, Clinical TherapeuticsI-December 2010
Rookie Physician of the Year 2001
Saint Francis Health Systems Endowed Chair of Pediatrics
Oklahoma State University College of Osteopathic Medicine:
Deans Honor Roll
Phi Kappa Phi Honor Society
Janet M. Glasgow Academic Achievement Citation
Sigma Sigma Phi Honor Society
University of Arkansas:
Golden Key Honor Society
Arkansas Alpha Epsilon Delta (Pre-Med Honor Society)
Northeastern State University:
Community College Connections Scholarship-Academics and Leadership
Connors State College:
Athletic Scholarship-Women’s Fast Pitch Softball
Provost and Dean’s Honor Roll
Who’s Who in American Junior Colleges
Phi Theta Kappa Honor Society
Distinguished Academic All American